Schmalfeld, Germany

Günter Bauer

This inventor holds 1 USPTO granted patent and 4 published patent applications and 5 EPO patents. Top assignees: Transimmune Ag, Yale University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Günter Bauer. Retrieved from https://idiyas.com/inventor/günter-bauer-mb7cf485

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Günter Bauer

Introduction

Günter Bauer is a notable inventor based in Schmalfeld, Germany. He has made significant contributions to the field of immunology, particularly in the development of methods for producing immuno-stimulatory autologous dendritic cells. His work has implications for treating patients with hyper-proliferative diseases, such as cancer.

Latest Patents

Günter Bauer holds a patent for a "Method for obtaining globally activated monocytes." This invention relates to innovative techniques for producing dendritic cells that can stimulate the immune system, offering potential therapeutic benefits for cancer patients.

Career Highlights

Throughout his career, Günter Bauer has worked with prominent organizations, including Transimmune AG and Yale University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Günter Bauer has collaborated with notable colleagues, including Justin Duckworth and Robert Tigelaar. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Günter Bauer's innovative work in immunology and his patent for producing dendritic cells highlight his contributions to medical science. His efforts continue to pave the way for advancements in cancer treatment and immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…